Send the following on WhatsApp
Continue to ChatImproved disease-free survival in endometrial and ovarian cancer patients with low folate binding protein expression after treatment with the E39 peptide vaccine in a phase I/IIa trial https://www.sages.org/meetings/annual-meeting/abstracts-archive/improved-disease-free-survival-in-endometrial-and-ovarian-cancer-patients-with-low-folate-binding-protein-expression-after-treatment-with-the-e39-peptide-vaccine-in-a-phase-i-iia-trial/